• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.09%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqGM
    0.48 Up 0.01(1.26%) 12:49PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.47
    Open:0.47
    Bid:0.48 x 100
    Ask:0.48 x 800
    1y Target Est:5.67
    Beta:2.86
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:0.46 - 0.48
    52wk Range:0.36 - 3.47
    Volume:114,855
    Avg Vol (3m):1,486,200
    Market Cap:44.01M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTX

    Comparison

    Symbol% ChgMkt Cap
    CYTXUp 1.26%44.01M
    ASTMDown 0.90%N/A
    BAXUp 0.38%38.83B
    OSIRDown 1.10%570.91M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.96
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.47
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback